Preventive Effects of Fluvastatin on Experimental Pulmonary Arterial Hypertension and Caveolin-1 Expression in Rats

ZHU Shaoping,MAO Zhifu,HUANG Jie,WANG Junyu
DOI: https://doi.org/10.14188/j.1671-8852.2010.01.005
2010-01-01
Abstract:Objective:To investigate the preventive effect of fluvastatin on experimental pulmonary arterial hypertension(PAH),and to explore the possible relations between caveolin-1 and PAH in rats.Methods:A total of 98 rats were randomly distributed into three groups as M+F group,treated with monocrotaline(MCT,30 mg/kg subcutaneous injection for one week) plus fluvastatin(1 mg/kg per day by gavage for six weeks),MCT group,treated only with MCT plus normal saline,and saline group,treated with normal saline.Mean pulmonary arterial pressure(mPAP),right ventricular hypertrophy index(RVHI) and caveolin-1 protein expressions were detected every two weeks during the six weeks' observation.Results:In week 4,mPAP and RVHI in MCT group were significantly higher than those of saline group.However,difference between M+F group and saline group in mPAP was observed until week 6,and no difference was observed in RVHI among the three groups during 6-week period.A significantly downregulated caveolin-1 expression was observed in week 2.Further extremely significant downregulation of caveolin-1 expression was observed in the following 4 weeks.No significant downregulation of caveolin-1 was observed in M+F group within 6 weeks.Conclusion:The downregulation of caveolin-1 expression is an important trigger for the induction of PAH.The effect of fluvastatin protecting against the formation of experimental pulmonary arterial hypertension correlates with caveolin-1 inhibition in rats.
What problem does this paper attempt to address?